BioCryst Pharma (BCRX) Tops Q4 EPS by 108c; offers outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 7.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.78 | 52 Week High | $10.98 | |||
| Open | $7.78 | 52 Week Low | $1.63 | |||
| Day High | $7.78 | P/E | N/A | |||
| Day Low | $7.78 | EPS | $-0.68 | |||
| Volume | 1,791 | |||||
